ImmunityBio Hosts Inaugural US-Saudi Biotech Alliance Summit

Reuters
01/12
ImmunityBio Hosts Inaugural US-Saudi Biotech Alliance <a href="https://laohu8.com/S/SMMT">Summit</a>

ImmunityBio Inc., in partnership with NantWorks, will host the inaugural U.S.-Saudi Biotech Alliance Summit on January 14, 2026, in San Francisco. The summit will bring together leaders from the United States and Saudi Arabia to accelerate innovation in immunotherapy, AI-enabled biomanufacturing, and global health security. The event will feature keynote addresses, panel discussions, and sessions focused on scientific and technological advances in healthcare.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112462615) on January 12, 2026, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10